Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ulenistamab (PBP1510) is a first-in-class humanized IgG1 monoclonal antibody that targets the pancreatic adenocarcinoma upregulated factor (PAUF), and is utilized in pancreatic cancer (PC) research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Ulenistamab (PBP1510) is a first-in-class humanized IgG1 monoclonal antibody that targets the pancreatic adenocarcinoma upregulated factor (PAUF), and is utilized in pancreatic cancer (PC) research [1]. |
In vitro | Ulenistamab (PBP1510) inhibits the proliferation of pancreatic cancer cell lines (CFPAC-1 and BxPC-3). Concurrently, there is a significant reduction in the migration and invasion of these cell lines [1]. |
In vivo | The pharmacokinetic (PK) profiles and immunogenicity of Ulenistamab (PBP1510) (up to 20 mg/kg) were examined in a single-dose study involving 6 monkeys. Systemic exposure in the monkey study was observed to increase in a dose-proportional manner at both low and high doses [1]. |
Synonyms | PBP1510 |
Molecular Weight | N/A |
CAS No. | 2415259-90-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ulenistamab 2415259-90-2 PBP 1510 PBP-1510 PBP1510 inhibitor inhibit